Patients with high baseline exercise capacity benefit from cardiac rehabilitation and exercise training programs.

Abstract:

:Despite the well-proven benefits of cardiac rehabilitation and exercise training, no data are available on the benefits of this therapy in patients with preserved baseline exercise capacity. Therefore we assessed data before and after phase II cardiac rehabilitation and exercise programs at two large teaching institutions to determine the benefits in 163 patients with high baseline exercise capacity (> or = 6 estimated [mean 8.8 +/- 2.4] metabolic equivalents [METs]) compared with 125 patients with low baseline functional capacity (< 6 estimated [mean 4.6 +/- 0.8] METs). After cardiac rehabilitation and exercise training, patients with high baseline exercise capacity had significant improvements in triglyceride (-10%; p < 0.05), high-density lipoprotein cholesterol (+7%; p < 0.001), and low-density lipoprotein cholesterol (-4%; p = 0.09) levels; low-density lipoprotein/high-density lipoprotein ratio (-10%; p < 0.01); body mass index (-1.5%; (p < 0.001); percent body fat (-6%; p < 0.0001); and exercise capacity (+22%; p < 0.0001). Patients with high baseline exercise capacity had less relative improvement in exercise capacity (p < 0.0001) after cardiac rehabilitation but had greater relative improvement in low-density lipoprotein cholesterol level (p < 0.05) and low-density lipoprotein/high-density lipoprotein ratio (p < 0.05) than did patients with low baseline exercise capacity. These data demonstrate the benefits of cardiac rehabilitation and exercise training in patients with preserved exercise capacity and support routine referral of these patients to these programs after major cardiac events.

journal_name

Am Heart J

journal_title

American heart journal

authors

Lavie CJ,Milani RV

doi

10.1016/0002-8703(94)90740-4

subject

Has Abstract

pub_date

1994-12-01 00:00:00

pages

1105-9

issue

6 Pt 1

eissn

0002-8703

issn

1097-6744

pii

0002-8703(94)90740-4

journal_volume

128

pub_type

杂志文章
  • The incidence of cardiac events in Japanese men with atypical or nonanginal chest pain: a prospective study on the significance of exercise testing.

    abstract::The incidence of cardiac events in Japanese men (mean age 54 +/- 10 years) with atypical or nonanginal chest pain was assessed prospectively. Three groups of patients, those with typical angina (TA; n = 134), those with atypical angina (AA; n = 192), and those with nonanginal chest pain (NA; n = 311) were studied with...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(92)90802-3

    authors: Sato I,Nishijima H,Matsumura N,Nishida M,Okita K,Yasuda H

    更新日期:1992-06-01 00:00:00

  • The alpha1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study.

    abstract:BACKGROUND:The recovery of left ventricular function (LVF) after revascularization takes time. alpha-Adrenergic blockade acutely improves coronary blood flow and LVF, whereas the effects of more prolonged alpha-adrenergic blockade on LVF recovery after stenting are unknown. METHODS:In 32 patients (age 58 +/- 12 y) wit...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.ahj.2003.08.005

    authors: Kozàkovà M,Marco J,Heusch G,Bernies M,Bossi IM,Palombo C,Anguissola GB,Donatelli F,Laurent JP,Gregorini L

    更新日期:2004-02-01 00:00:00

  • Pharmacologic characteristics of a new calcium antagonist, manidipine: beneficial effects on renal circulation and vascular changes.

    abstract::The calcium antagonist, manidipine, was developed on the basis of the hypothesis that antihypertensive drugs that act to improve renal hemodynamic alterations will be therapeutically beneficial in hypertensive patients. Manidipine shows long-lasting calcium channel-blocking action in vascular smooth muscle cells and a...

    journal_title:American heart journal

    pub_type: 杂志文章,评审

    doi:10.1016/0002-8703(93)90203-l

    authors: Nagaoka A

    更新日期:1993-02-01 00:00:00

  • Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.

    abstract:BACKGROUND:The rise in cardiac troponin I after ST-elevation myocardial infarction treated by primary percutaneous coronary interventions (PCIs) is predictive of infarct size and left ventricular ejection fraction (LVEF). However, the comparative value of C-reactive protein (CRP) and troponin I for infarct size evaluat...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2006.07.016

    authors: Ohlmann P,Jaquemin L,Morel O,El Behlgiti R,Faure A,Michotey MO,Beranger N,Roul G,Schneider F,Bareiss P,Monassier JP

    更新日期:2006-12-01 00:00:00

  • Controlled-release drug delivery systems in cardiovascular medicine.

    abstract::Controlled-release drug delivery technology has had a significant effect on the pharmacotherapy of cardiovascular diseases. Oral and transcutaneous controlled-release systems allow relatively short-acting drugs to be administered once or twice daily with comparable therapeutic efficacy and fewer adverse reactions comp...

    journal_title:American heart journal

    pub_type: 杂志文章,评审

    doi:10.1016/0002-8703(95)90019-5

    authors: Katz B,Rosenberg A,Frishman WH

    更新日期:1995-02-01 00:00:00

  • Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

    abstract:BACKGROUND:Only limited data from large randomized clinical trials have been published on the long-term performance of second-generation drug-eluting stents in bifurcation lesions. METHODS:We investigated in patients in the randomized TWENTE trial the long-term safety and efficacy of treating bifurcation lesions with ...

    journal_title:American heart journal

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.ahj.2014.10.011

    authors: Lam MK,Sen H,van Houwelingen KG,Löwik MM,van der Heijden LC,Kok MM,de Man FH,Linssen GC,Tandjung K,Doggen CJ,von Birgelen C

    更新日期:2015-01-01 00:00:00

  • Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity.

    abstract:BACKGROUND:Chronic infection with Chlamydia pneumoniae (Cpn) has been associated with atherosclerotic cardiovascular disease in sero-epidemiological, pathological and animal-model studies. Inflammation and immune activation has been proposed as the pathophysiological link between chronic infection and atherosclerosis. ...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/S0002-8703(03)00101-7

    authors: Smith DA,Zouridakis EG,Mariani M,Fredericks S,Cole D,Kaski JC

    更新日期:2003-07-01 00:00:00

  • The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.

    abstract:BACKGROUND:Atrial fibrillation (AF) is associated with increased risk of death, thromboembolic complications, and a lowered quality of life. Despite this burden, pharmacologic agents for prevention of AF in patients who achieved normal sinus rhythm are of limited utility, mostly because of serious and frequent side eff...

    journal_title:American heart journal

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.ahj.2008.10.027

    authors: Macchia A,Varini S,Grancelli H,Nul D,Laffaye N,Ferrante D,Tognoni G,Doval HC,FORomegaARD investigators.

    更新日期:2009-03-01 00:00:00

  • Optimal features of a new beta-blocker.

    abstract::Therapeutics involves the careful balance between treatment disadvantages and advantages--the so-called risk-benefit ratio. Even after 20 years beta-blockers must be selected carefully to suit the patient's needs. This review examines several problems associated with beta-blockade. Generally, beta1-cardioselectivity i...

    journal_title:American heart journal

    pub_type: 杂志文章,评审

    doi:10.1016/0002-8703(88)90130-5

    authors: Reid JL

    更新日期:1988-11-01 00:00:00

  • Pathophysiologic mechanisms underlying dobutamine- and exercise-induced wall motion abnormalities.

    abstract:BACKGROUND:Dobutamine and exercise echocardiography are accepted as tests of comparable efficacy for the diagnosis of coronary artery disease. Although dobutamine has been classified as "exercise simulating," the mechanisms of ischemia with dobutamine and exercise have not been well studied. This study sought to compar...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/s0002-8703(98)70183-8

    authors: Mairesse GH,Vanoverschelde JL,Robert A,Climov D,Detry JM,Marwick TH

    更新日期:1998-07-01 00:00:00

  • Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.

    abstract::The antiarrhythmic effect of nadolol, a long-acting, nonselective beta antagonist without intrinsic sympathomimetic or membrane-stabilizing properties, was evaluated in 36 patients with ventricular dysrhythmias as determined by three baseline 24-hour Holter recordings at a time when subjects were receiving placebo. Na...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章

    doi:10.1016/0002-8703(84)90590-8

    authors: Nademanee K,Schleman MM,Singh BN,Morganroth J,Reid PR,Stritar JA

    更新日期:1984-10-01 00:00:00

  • Unusual manifestations of severe sick sinus syndrome.

    abstract::An extremely athletic 56-year-old male physician was found to have profound sinus bradycardia. His only symptom was markedly increased alertness while actively exercising. During pacemaker insertion he had an episode of prolonged sinus arrest terminated by a precordial thump. This case suggests that exercise can alter...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(80)90284-7

    authors: Marmor BM,Black MM

    更新日期:1980-07-01 00:00:00

  • Design of the RELAXin in acute heart failure study.

    abstract:BACKGROUND:Acute heart failure (AHF) remains a major public health burden with a high prevalence and poor prognosis. Relaxin is a naturally occurring peptide hormone that increases cardiac output, arterial compliance, and renal blood flow during pregnancy. The RELAX-AHF-1 study will evaluate the effect of RLX030 (recom...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.ahj.2011.10.009

    authors: Ponikowski P,Metra M,Teerlink JR,Unemori E,Felker GM,Voors AA,Filippatos G,Greenberg B,Teichman SL,Severin T,Mueller-Velten G,Cotter G,Davison BA

    更新日期:2012-02-01 00:00:00

  • Coronary restenosis: evaluation of a restenosis injury index in a swine model.

    abstract::To investigate the mechanisms of restenosis and detect useful interventions to prevent it, reliable quantitative measurements must be evaluated. Coronary arteries of domestic and minipigs (n = 18) were mechanically injured by balloon overstretching and killed at different intervals (2 to 25 weeks) after quantitative a...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(93)90531-d

    authors: Bonan R,Paiement P,Scortichini D,Cloutier MJ,Leung TK

    更新日期:1993-12-01 00:00:00

  • Ten-year clinical follow-up after sirolimus-eluting stent implantation.

    abstract:BACKGROUND:Little is known on the "very" long-term incidence of major adverse cardiac events (MACE), target-lesion revascularization (TLR), target-vessel revascularization and stent thrombosis after sirolimus-eluting stent (SES) implantation. We present the first study to provide a 10-year clinical follow-up in an unse...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2013.12.013

    authors: Palhais N,Arroyo D,Lehmann S,Togni M,Kaufmann U,Puricel SG,Stauffer JC,Goy JJ,Cook S

    更新日期:2014-06-01 00:00:00

  • A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial.

    abstract:BACKGROUND:The magnitude of benefit of cardiac resynchronization therapy (CRT) varies significantly among its recipients; approximately 30% of CRT patients do not report clinical improvement. Optimization of CRT pacing parameters can further improve cardiac function, both acutely and chronically. Echocardiographic opti...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.ahj.2012.02.007

    authors: Krum H,Lemke B,Birnie D,Lee KL,Aonuma K,Starling RC,Gasparini M,Gorcsan J,Rogers T,Sambelashvili A,Kalmes A,Martin D

    更新日期:2012-05-01 00:00:00

  • Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study.

    abstract:BACKGROUND:Although there is evidence linking smoking and heart failure (HF), the association between lifetime smoking exposure and HF in older adults and the strength of this association among current and past smokers is not well known. METHODS:We examined the association between smoking status, pack-years of exposur...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2012.05.013

    authors: Gopal DM,Kalogeropoulos AP,Georgiopoulou VV,Smith AL,Bauer DC,Newman AB,Kim L,Bibbins-Domingo K,Tindle H,Harris TB,Tang WW,Kritchevsky SB,Butler J

    更新日期:2012-08-01 00:00:00

  • Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE).

    abstract:BACKGROUND:A subset of patients hospitalized with acute heart failure experiences in-hospital worsening heart failure, defined as persistent or worsening signs or symptoms requiring an escalation of therapy. METHODS:We analyzed data from the Acute Decompensated Heart Failure National Registry (ADHERE) linked to Medica...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2016.04.021

    authors: DeVore AD,Greiner MA,Sharma PP,Qualls LG,Schulte PJ,Cooper LB,Mentz RJ,Pang PS,Fonarow GC,Curtis LH,Hernandez AF

    更新日期:2016-08-01 00:00:00

  • Clinical implications of exercise-induced chest pain: comparison of patients with and without pathologic Q waves in coronary artery disease.

    abstract::We attempted to determine whether exercise-induced silent myocardial ischemia has different clinical implications in patients with and without pathologic Q waves. We studied 152 patients (121 men and 31 women) who had ischemic ST depression (greater than or equal to 0.05 mV) during exercise tests and greater than or e...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(90)90009-m

    authors: Ozawa T,Ikeda K,Yamaki M,Kubota I,Tsuiki K,Yasui S

    更新日期:1990-09-01 00:00:00

  • Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.

    abstract:BACKGROUND:Erythropoietin mitigates myocardial damage and improves ventricular performance after experimental ischemic injury. This study assessed safety and efficacy markers relevant to the biological activity of recombinant human erythropoietin (rHuEpo) in patients with acute myocardial infarction (MI). METHODS:We c...

    journal_title:American heart journal

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.ahj.2009.06.032

    authors: Tang YD,Hasan F,Giordano FJ,Pfau S,Rinder HM,Katz SD

    更新日期:2009-12-01 00:00:00

  • The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).

    abstract:BACKGROUND:Embolic events to the central nervous system are a major cause of morbidity and mortality in patients with infective endocarditis (IE). The appropriate role of valvular surgery in reducing such embolic events is unclear. The purpose of this study was to determine the relationship between the initiation of an...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2007.07.023

    authors: Dickerman SA,Abrutyn E,Barsic B,Bouza E,Cecchi E,Moreno A,Doco-Lecompte T,Eisen DP,Fortes CQ,Fowler VG Jr,Lerakis S,Miro JM,Pappas P,Peterson GE,Rubinstein E,Sexton DJ,Suter F,Tornos P,Verhagen DW,Cabell CH,ICE In

    更新日期:2007-12-01 00:00:00

  • Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators.

    abstract:BACKGROUND:Most analyses of complications after percutaneous coronary intervention have been limited to angiographic predictors of abrupt closure. We sought to determine the relation between baseline clinical and angiographic characteristics and clinical ischemic events and whether treatment with the platelet glycoprot...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1053/hj.1999.v137.92521

    authors: Thel MC,Califf RM,Tcheng JE,Sigmon KN,Lincoff AM,Topol EJ,Ellis SG

    更新日期:1999-02-01 00:00:00

  • The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study.

    abstract:BACKGROUND:Previous studies with dexamethasone-eluting stents could not elucidate the role of dexamethasone in the prevention of neointimal hyperplasia because they did not compare their results with a control group. We prospectively evaluated the clinical and angiographic outcomes of dexamethasone-eluting stents, comp...

    journal_title:American heart journal

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.ahj.2006.05.011

    authors: Han SH,Ahn TH,Kang WC,Oh KJ,Chung WJ,Shin MS,Koh KK,Choi IS,Shin EK

    更新日期:2006-11-01 00:00:00

  • Impact of computerized dosing on eptifibatide-associated bleeding and mortality.

    abstract:OBJECTIVE:The study aimed to determine the impact on eptifibatide-associated bleeding by implementing a computerized dosing algorithm in the cardiac catheterization suite. BACKGROUND:Excessive dosing of eptifibatide is associated with increased bleeding rates and hospital mortality. Although dosing adjustments based o...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2009.10.006

    authors: Putney DR,Kleiman NS,Fromm RE Jr,Buergler JM

    更新日期:2009-12-01 00:00:00

  • Is the dyspnea during adenosine cardiac stress test caused by bronchospasm?

    abstract:BACKGROUND:Adenosine cardiac stress is widely used as an alternative to exercise testing during myocardial perfusion imaging (MPI). Dyspnea often accompanies the adenosine stress test. Although known asthmatic patients are excluded from this test because of the danger of bronchospasm, there is incomplete information re...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1067/mhj.2001.116070

    authors: Balan KK,Critchley M

    更新日期:2001-07-01 00:00:00

  • EMERGEncy versus delayed coronary angiogram in survivors of out-of-hospital cardiac arrest with no obvious non-cardiac cause of arrest: Design of the EMERGE trial.

    abstract:BACKGROUND:In adults, the most common cause of out-of-hospital cardiac arrests (OHCA) is acute coronary artery occlusion. If an immediate coronary angiogram (CAG) is recommended for survivors presenting a ST segment elevation on the electrocardiogram (ECG) performed after resuscitation, there is still a debate regardin...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.ahj.2020.01.006

    authors: Hauw-Berlemont C,Lamhaut L,Diehl JL,Andreotti C,Varenne O,Leroux P,Lascarrou JB,Guerin P,Loeb T,Roupie E,Daubin C,Beygui F,Vilfaillot A,Glippa S,Djadi-Prat J,Chatellier G,Cariou A,Spaulding C,EMERGE investigators.

    更新日期:2020-04-01 00:00:00

  • Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.

    abstract::High levels of endogenous plasma catecholamines in patients with severe congestive heart failure induce a down-regulation of the myocardial beta-adrenoreceptors and thus cause adrenoreceptor agonists, such as dobutamine, to be less effective in the treatment of these patients. Phosphodiesterase III inhibitors work ind...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章

    doi:10.1016/0002-8703(91)90834-5

    authors: Mager G,Klocke RK,Kux A,Höpp HW,Hilger HH

    更新日期:1991-06-01 00:00:00

  • Does ST resolution achieved via different reperfusion strategies (fibrinolysis vs percutaneous coronary intervention) have different prognostic meaning in ST-elevation myocardial infarction? A systematic review.

    abstract:OBJECTIVE:We perform a systematic review to discern if ST resolution achieved via percutaneous coronary intervention (PCI) has a different meaning to that achieved via fibrinolysis. BACKGROUND:Resolution of ST-segment elevation in acute myocardial infarction has been widely used as a surrogate for treatment success. A...

    journal_title:American heart journal

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.ahj.2010.06.050

    authors: Wong CK,de la Barra SL,Herbison P

    更新日期:2010-11-01 00:00:00

  • Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial.

    abstract:BACKGROUND:Anxiety is highly prevalent among patients with coronary heart disease (CHD), and there is growing evidence that high levels of anxiety are associated with worse prognosis. However, few studies have evaluated the efficacy of treating anxiety in CHD patients for reducing symptoms and improving clinical outcom...

    journal_title:American heart journal

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.ahj.2016.03.003

    authors: Blumenthal JA,Feger BJ,Smith PJ,Watkins LL,Jiang W,Davidson J,Hoffman BM,Ashworth M,Mabe SK,Babyak MA,Kraus WE,Hinderliter A,Sherwood A

    更新日期:2016-06-01 00:00:00

  • Prospective evaluation of shoulder-related problems in patients with pectoral cardioverter-defibrillator implantation.

    abstract:BACKGROUND:The pectoral approach to implantation of cardioverter defibrillators (ICDs) has become a standard in defibrillator therapy because of reduced generator size, weight, and volume. But the size of these devices is still comparable to the size of the early conventional antibradycardia pacemakers that were associ...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/s0002-8703(98)70270-4

    authors: Korte T,Jung W,Schlippert U,Wolpert C,Esmailzadeh B,Fimmers R,Schmitt O,Lüderitz B

    更新日期:1998-04-01 00:00:00